|
Author | Li H et al. | Choi HR et al. | Ibrahim MS et al. | Huang R et al. | Berbari EF et al. | Malekzadeh D et al. | Kim YH et al. | Kim YH et al. |
|
Title | Two-stage revisions for culture-negative infected total knee arthroplasties: A five-year outcome in comparison with one-stage and two-stage revisions for culture-positive cases. | Periprosthetic joint infection with negative culture results: Clinical characteristics and treatment outcome. | Two-stage revision for the culture-negative infected total hip arthroplasty. | Culture-negative periprosthetic joint infection does not preclude infection control. | Culture-negative Prosthetic Joint Infection. | Prior Use of Antimicrobial Therapy is a Risk Factor for Culture-negative Prosthetic Joint Infection. | Comparison of infection control rates and clinical outcomes in culture-positive and culture-negative infected total-knee arthroplasty. | The outcome of infected total knee arthroplasty: culture-positive versus culture-negative. |
|
Year | 2017 | 2013 | 2017 | 2012 | 2007 | 2010 | 2015 | 2015 |
|
Country | Netherlands | United States | UK | United States | United States | United States | Korea | Korea |
|
LoE | III | III | III | III | III | III | III | III |
|
Study design | Retrospective | Retrospective | Prospective | Retrospective | Retrospective | Retrospective | Retrospective | Retrospective |
|
Study Type | Case-Control study | Case-Control study | Case-Control study | Case-Control study | Cohort study | Case-Control study | Case-Control study | Case-Control study |
|
Treatment interval | 2003-2014 | 2000-2009 | 2007-2012 | 2000-2007 | 1990-1999 | 1985-2000 | 2001-2008 | 1991-2008 |
|
Total number of cases | 129 | 175 | - | 295 | 897 | 1413 | 242 | 191 |
|
Prevalence of CN cases % | 14.2 | 23 | - | 16.3 | 7 | 10.5 | 42.1 | 26.7 |
|
Hip % | - | 50 | 100 | 43.8 | 45 | 50 | - | - |
|
Knee % | 100 | 50 | - | 56.2 | 55 | 50 | 100 | 100 |
|
FU in months, median | 55.6 | 52 | 60 | 47 | 36-60 | 56 | 127.2 | 127.2 |
|
Risk factors | | - | (1) prior use of antibiotics (2) referral from elsewhere (3) age | | (1) prior use of antibiotics (within 3 months) | (1) prior use of antibiotics (in 64%) (2) prolonged wound drainage after index arthroplasty (residual confounder) | - | - |
|
Debridement n | - | 11 | - | 12 | 12 | 18 | 56 | 28 |
|
1-stage n | | | | 3 | 5 | 8 | - | - |
|
2-stage n | 18 | 23 | 50 | 33 | 34 | 56 | 46 | 23 |
|
Permanent resection n | | - | - | - | 8 | 34 | - | - |
|
Other therapy | | 6 | - | - | 1 | 19 | - | - |
|
Antibiotic treatment after diagnosis % | Vancomycin 33 Vancomycin + Ceftriaxone 33 Others 34 | Vancomycin 70; Others 30 | - | Vancomycin 81; Cephalosporins 10; Others 9 | Cephalosporins 82; Vancomycin 12; Others 6 | Cefazolin 69; Vancomycin 13; Others/None 18 | Vancomycin 85; Others 15 | Vancomycin 86; Others 14 |
|
Successful treatment in % | 88,9 | 85 | 94 | - | - | - | 95 | 95 |
|
Overall infection free survival rate % 1.) 3-year 2.) 5-year | - | - | 1.) - 2.) 94 | 73 | - | 1.) - 2.) 67 | - | - |
|
I&D infection free survival rate % 1.) 3-year 2.) 5-year | - | - | - | 50 | 1.) - 2.) 71 | 78 | 57 | 61 |
|
2-Stage infection free survival rate % 1.) 3-year 2.) 5-year | 1.) 75 2.) 95 | - | - | 58 | 1.) - 2.) 94 | 1.) 87 2.) 79 | 83 | 83 |
|
1-Stage infection free survival rate % 1.) 3-year 2.) 5-year | - | - | - | 100 | - | - | - | - |
|
Resection arthroplasty infection free survival rate % 1.) 3-year 2.) 5-year | - | - | - | - | 1.) 51 | 1.) 49 2.) 43 | - | - |
|
Outcome | With combined or broad-spectrum antibiotics, two-stage revision showed comparable outcome in satisfaction rates, reinfections rates and cumulative survival rates at 5-year Follow-up with CP PJI patients. | The success rate of infection control was higher in the CN group, which suggests that CN may not necessarily be a negative prognostic factor for PJI. | - | The overall infection control rate was similar between CP and CN PJI cases (both 73%). | The outcome of CN PJI is similar to the outcome of PJI due to known pathogens. | The demographics and outcome of CP and CN PJI patients were similar (free of treatment failure at 2 years 79% and 75%). | The infection control rates and clinical outcomes were not different between CP and CN groups (overall infection control rates 90% and 95%). | Overall rates of infection control, successful treatment, and functional outcomes were not different between the CP and CN groups (overall infection control rates 90% and 95%). |
|